A Study to Evaluate the Efficacy and Safety of Clevudine and Peg-interferon in Sequence Compared With Clevudine Alone in the Patients With HBeAg(+) CHB or Clevudine and Peg-interferon Sequential Treatment in Patients With CHB Who Have HBeAg(+).
Phase of Trial: Phase IV
Latest Information Update: 22 Dec 2014
At a glance
- Drugs Clevudine (Primary) ; Peginterferon alfa-2a
- Indications Hepatitis B
- Focus Therapeutic Use
- Sponsors Bukwang Pharmaceutical
- 17 Dec 2014 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
- 25 Jul 2012 Planned end date changed from 1 Dec 2012 to 1 Dec 2014 as reported by ClinicalTrials.gov.
- 25 Dec 2010 New trial record